Helix Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer with a history dating to 1960 and a broad prescription and consumer-health portfolio.
Helix Pharma products in Pakistan
Helix Pharma (Pvt)., Ltd has 113 medicine presentations registered in Pakistan under 49 brands, covering 45 generic medicines. Most of its products are in Anti-infectives, Oncology & immunology and CNS & mental health. Its brands with the most registered strengths and packs are Relidomide (Lenalidomide), Eplipsa (Levetiracetam), Hilixophin (Ceftriaxone) and Recept (Risperidone). 113 products have an official DRAP price on MedInfoBase. See all 49 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Helix Pharma (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- A-56 Manghopir Road, Metroville, S.I.T.E., Karachi, Pakistan
- Website
- helix-ph.com ↗
- Phone
- +92 21 111 475 475
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Helix Pharma (Pvt)., Ltd. is priced against the market
105 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 49 Helix Pharma brands in Pakistan
- Artepip 40/320 Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule
- Aslow - 81 EachEnteric Coated Acetylsalicylic acid (Aspirin) · 81 mg tablet
- Ayzed Azithromycin · 200 mg/5 mL suspension, 500 mg tablet
- Bicluta Bicalutamide · 50 mg tablet
- Carbol Carboplatin · 150 mg/15 mL injection, 450 mg/45 mL (10 mg/mL) injection
- Citabol Gemcitabine · 1000 mg injection, 200 mg injection
- Clotamax Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
- Cocard Clopidogrel · 75 mg tablet
- Cocard Plus 75/75 Clopidogrel + Aspirin · 75 mg + 75 mg tablet
- Cytomib Bortezomib · 3.5 mg injection
- Declar Daclatasvir · 30 mg tablet, 60 mg tablet
- Diaxin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Doris Cholecalciferol · 5 mg/mL (200,000 IU/mL) injection
- EM-Fera Empagliflozin · 10 mg tablet, 25 mg tablet
- Eplipsa Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
- Eplipsa XR Levetiracetam · 500 mg tablet
- Erlotirel Erlotinib · 100 mg tablet, 150 mg tablet
- Fotiflox Moxifloxacin · 400 mg tablet
- Fugix Fluconazole · 150 mg capsule, 50 mg capsule, 50 mg/5 mL suspension
- Hi-Sunate Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
- Hilixophin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Hipro Ciprofloxacin · 100 mg tablet, 250 mg tablet, 500 mg tablet
- Hipro XR Ciprofloxacin · 1000 mg tablet
- Hitac Ranitidine · 150 mg tablet
- Hitaxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Hitazidime Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
- Hixopenem Meropenem · 1 g injection, 500 mg injection
- Ironal Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup
- Ironal-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- Mether Artemether · 40 mg injection
- Misolix Misoprostol · 100 mcg tablet, 200 mcg tablet
- Neu peg PF S Pegfilgrastim · 6 mg/0.6 mL injection
- Oflocin Ear Ofloxacin · 0.3 % drops, 0.6 % drops
- Oxol Oxaliplatin · 100 mg/50 mL (2 mg/mL) injection, 50 mg/25 mL injection
- Recept Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Relicitabine Capecitabine · 150 mg tablet, 500 mg tablet
- Relidomide Lenalidomide · 10 mg capsule, 25 mg capsule, 5 mg capsule
- Robol Doxorubicin · 10 mg/5 mL injection, 50 mg/25 mL injection
- Sedol Etoposide · 100 mg/5 mL (20 mg/mL) injection
- Sofotel Sofosbuvir · 400 mg tablet
- Tavelor Loratadine · 10 mg tablet, 5 mg/5 mL suspension
- Trexol Methotrexate · 50 mg/2 mL injection
- Tycef Cefixime · 400 mg capsule
- Tycef DS Cefixime · 200 mg/5 mL suspension
- Tycef Pediatric Cefixime · 100 mg/5 mL suspension
- Winy Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- Xeflox Levofloxacin · 250 mg tablet, 500 mg tablet
- Ximab Rituximab · 100 mg/10 mL (10 mg/mL) infusion, 500 mg infusion
- Zavir Ribavirin · 400 mg tablet, 600 mg tablet
Helix Pharma: common questions
How many products does Helix Pharma have in Pakistan?
Helix Pharma (Pvt)., Ltd has 113 registered medicine presentations in Pakistan, sold under 49 brands and covering 45 generic medicines.
What are the main brands of Helix Pharma?
By number of registered strengths and packs, its largest brands are Relidomide (Lenalidomide), Eplipsa (Levetiracetam), Hilixophin (Ceftriaxone), Recept (Risperidone) and Hipro (Ciprofloxacin). This is not a sales ranking.
Which therapy areas does Helix Pharma cover?
The most products are in Anti-infectives (51), Oncology & immunology (27), CNS & mental health (13), Hematology & thrombosis (6) and Vitamins, minerals & nutrition (6).
Where can I see Helix Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.